» Articles » PMID: 27231438

Induction of G1-phase Cell Cycle Arrest and Apoptosis Pathway in MDA-MB-231 Human Breast Cancer Cells by Sulfated Polysaccharide Extracted from Laurencia Papillosa

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2016 May 28
PMID 27231438
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Marine algae consumption is linked to law cancer incidences in countries that traditionally consume marine products. Hence, Phytochemicals are considered as potential chemo-preventive and chemotherapeutic agents against cancer. We investigated the effects of the algal sulfated polysaccharide extract (ASPE) from the red marine alga L. papillosa on MDA-MB-231 human breast cancer cell line.

Methods: Flow cytometry analysis was performed to study the cell viability, cell cycle arrest and apoptosis. Changes in the expression of certain genes associated with cell cycle regulation was conducted by PCR real time analyses. Further investigations on apoptotic molecules was performed by ROS measurement and protein profiling.

Results: ASPE at low doses (10 µg/ml), inhibited cell proliferation, and arrested proliferating MDA-MB-231 cells at G1-phase. However, higher doses (50 µg/ml), triggered apoptosis in those cells. The low dose of ASPE also caused up-regulation of Cip1/p21 and Kip1/p27 and down-regulation of cyclins D1, D2, and E1 transcripts and their related cyclin dependent kinases: Cdk2, Cdk4, and Cdk6. The higher doses of ASPE initiated a dose-dependent apoptotic death in MDA-MB-231 by induction of Bax transcripts, inhibition of Bcl-2 and cleavage of Caspase-3 protein. Over-generation of reactive oxygen species (ROS) were also observed in MDA-MB-231 treated cells.

Conclusions: These findings indicated that ASPE induces G1-phase arrest and apoptosis in MDA-MB-231 cells. ASPE may serve as a potential therapeutic agent for breast cancer.

Citing Articles

Energy metabolism in health and diseases.

Liu H, Wang S, Wang J, Guo X, Song Y, Fu K Signal Transduct Target Ther. 2025; 10(1):69.

PMID: 39966374 PMC: 11836267. DOI: 10.1038/s41392-025-02141-x.


Gintonin-Enriched Extract Induces Apoptosis in Human Melanoma Cells by Causing Cell Cycle Arrest and Activating Caspases.

Lee S, Park G, Lee R, Hong S, Han S, Lee Y Foods. 2025; 14(3).

PMID: 39941974 PMC: 11816885. DOI: 10.3390/foods14030381.


JQ1 Treatment and miR-21 Silencing Activate Apoptosis of CD44+ Oral Cancer Cells.

Jaksic Karisik M, Lazarevic M, Mitic D, Ajtic O, Damante G, Milasin J Int J Mol Sci. 2025; 26(3).

PMID: 39941011 PMC: 11818616. DOI: 10.3390/ijms26031241.


A select inhibitor of MORC2 encapsulated by chimeric membranecoated DNA nanocage target alleviation TNBC progression.

Su X, Luo Y, Wang Y, Qu P, Liu J, Han S Mater Today Bio. 2025; 31:101497.

PMID: 39906202 PMC: 11791359. DOI: 10.1016/j.mtbio.2025.101497.


Exploring the potential of gemcitabine-metal-organic frameworks in combating pancreatic cancer under ketogenic conditions.

Nekoufar S, Ghorbani M, Safaei S, Khosroushahi G, Shirian F, Baradaran B BMC Cancer. 2025; 25(1):53.

PMID: 39789481 PMC: 11720622. DOI: 10.1186/s12885-024-13397-x.


References
1.
Riedl S, Shi Y . Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol. 2004; 5(11):897-907. DOI: 10.1038/nrm1496. View

2.
Gamal-Eldeen A, Ahmed E, Abo-Zeid M . In vitro cancer chemopreventive properties of polysaccharide extract from the brown alga, Sargassum latifolium. Food Chem Toxicol. 2009; 47(6):1378-84. DOI: 10.1016/j.fct.2009.03.016. View

3.
Toyoshima H, Hunter T . p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 1994; 78(1):67-74. DOI: 10.1016/0092-8674(94)90573-8. View

4.
Ravikumar S, Inbaneson S, Suganthi P . Seaweeds as a source of lead compounds for the development of new antiplasmodial drugs from South East coast of India. Parasitol Res. 2010; 109(1):47-52. DOI: 10.1007/s00436-010-2219-x. View

5.
Sun S, Huang H, Huang C, Lin J . Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin. Eur J Pharmacol. 2012; 690(1-3):22-30. DOI: 10.1016/j.ejphar.2012.05.036. View